MMA
LLY icon

Miracle Mile Advisors’s Eli Lilly LLY Stock Holding History

Miracle Mile Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5M Buy
22,959
+815
+4% +$833K 0.32% 67
2026
Q1 		$20.4M Buy
22,144
+1,089
+5% +$1.1M 0.28% 74
2025
Q4 		$22.6M Buy
21,055
+1,289
+7% +$1.23M 0.32% 66
2025
Q3 		$15.1M Buy
19,766
+1,447
+8% +$1.08M 0.23% 86
2025
Q2 		$14.3M Buy
18,319
+5,043
+38% +$3.92M 0.24% 77
2025
Q1 		$11M Sell
13,276
-37
-0.3% -$30.8K 0.22% 76
2024
Q4 		$10.3M Buy
13,313
+6,294
+90% +$5.21M 0.21% 77
2024
Q3 		$6.22M Buy
7,019
+609
+10% +$548K 0.14% 95
2024
Q2 		$5.8M Buy
6,410
+667
+12% +$534K 0.14% 96
2024
Q1 		$4.47M Buy
5,743
+600
+12% +$427K 0.11% 117
2023
Q4 		$3M Buy
5,143
+489
+11% +$285K 0.08% 143
2023
Q3 		$2.5M Buy
4,654
+27
+0.6% +$13.9K 0.08% 154
2023
Q2 		$2.17M Sell
4,627
-400
-8% -$168K 0.07% 174
2023
Q1 		$1.73M Buy
5,027
+94
+2% +$31.7K 0.06% 209
2022
Q4 		$1.8M Buy
4,933
+693
+16% +$246K 0.06% 209
2022
Q3 		$1.37M Buy
4,240
+2,243
+112% +$711K 0.06% 176
2022
Q2 		$647K Buy
1,997
+473
+31% +$142K 0.03% 268
2022
Q1 		$437K Sell
1,524
-14,704
-91% -$3.78M 0.02% 338
2021
Q4 		$4.48M Buy
16,228
+101
+0.6% +$25.6K 0.17% 107
2021
Q3 		$3.73M Sell
16,127
-84
-0.5% -$20.7K 0.18% 113
2021
Q2 		$3.72M Sell
16,211
-1,638
-9% -$329K 0.2% 100
2021
Q1 		$3.33M Sell
17,849
-694
-4% -$136K 0.19% 104
2020
Q4 		$3.13M Buy
18,543
+447
+2% +$66.7K 0.19% 110
2020
Q3 		$2.68M Buy
18,096
+3,226
+22% +$499K 0.19% 111
2020
Q2 		$2.44M Buy
+14,870
New +$2.28M 0.2% 108

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Miracle Mile Advisors's LLY Position: Q2 2026 in Review

Miracle Mile Advisors increased its Eli Lilly (LLY) stake by 3.7% in Q2 2026, buying an estimated $833K and bringing the position to 22,959 shares worth $27.5M. The position accounts for 0.32% of the portfolio, ranked #67.

Miracle Mile Advisors first reported a position in LLY in Q2 2020 and has held it in 25 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Miracle Mile Advisors held 22,959 shares of Eli Lilly worth $27.5M as of Q2 2026.
  • Miracle Mile Advisors bought 815 Eli Lilly shares in Q2 2026, an estimated $833K.
  • Eli Lilly made up 0.32% of Miracle Mile Advisors's portfolio in Q2 2026, its #67 holding.
  • Miracle Mile Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 25 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.